VIVUS (VVUS) Ticks Lower on Arena (ARNA) Headlines
Tweet
Share
E-mailGet Alerts VVUS Hot Sheet
Join SI Premium – FREE
VIVUS Inc. (Nasdaq: VVUS) seeing activity on word an FDA panel backed a competing obesity drug from Arena Pharmaceuticals, Inc. (Nasaq: ARNA).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Buyout firm Vista explores $3B sale of private markets data provider Allvue - Reuters
- Gossamer Bio raises up to $250M in private placement for PAH drug
Create E-mail Alert Related Categories
FDA, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
